Skip to main content
PMC home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1958 May;34(5):287–296.

Renal Regulation of Uric Acid Excretion in Normal and Gouty Man: Modification by Uricosuric Agents*

Alexander B Gutman, T'sai Fan Yü
PMCID: PMC1805882  PMID: 13523299

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERLINER R. W., HILTON J. G., YU T. F., KENNEDY T. J. The renal mechanism for urate excretion in man. J Clin Invest. 1950 Apr;29(4):396–401. doi: 10.1172/JCI102271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERLINER R. W., KENNEDY T. J., Jr, HILTON J. G. Renal mechanisms for excretion of potassium. Am J Physiol. 1950 Aug 1;162(2):348–367. doi: 10.1152/ajplegacy.1950.162.2.348. [DOI] [PubMed] [Google Scholar]
  3. BEYER K. H. Factors basic to the development of useful inhibitors of renal transport mechanisms. Arch Int Pharmacodyn Ther. 1954 May 1;98(1):97–117. [PubMed] [Google Scholar]
  4. BURNS J. J., YU T. F., RITTERBAND A., PEREL J. M., GUTMAN A. B., BRODIE B. B. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther. 1957 Mar;119(3):418–426. [PubMed] [Google Scholar]
  5. Coombs F. S., Pecora L. J., Thorogood E., Consolazio W. V., Talbott J. H. RENAL FUNCTION IN PATIENTS WITH GOUT. J Clin Invest. 1940 May;19(3):525–535. doi: 10.1172/JCI101156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GUTMAN A. B., YU T. F. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians. 1951;64:279–288. [PubMed] [Google Scholar]
  7. GUTMAN A. B., YU T. F. Prevention and treatment of chronic gouty arthritis. J Am Med Assoc. 1955 Mar 26;157(13):1096–1102. doi: 10.1001/jama.1955.02950300024005. [DOI] [PubMed] [Google Scholar]
  8. GUTMAN A. B., YU T. F. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med. 1957 Oct;23(4):600–622. doi: 10.1016/0002-9343(57)90231-0. [DOI] [PubMed] [Google Scholar]
  9. POULSEN H., PRAETORIUS E. Tubular excretion of uric acid in rabbits. Acta Pharmacol Toxicol (Copenh) 1954;10(4):371–378. doi: 10.1111/j.1600-0773.1954.tb01353.x. [DOI] [PubMed] [Google Scholar]
  10. PRAETORIUS E., KIRK J. E. Hypouricemia: with evidence for tubular elimination of uric acid. J Lab Clin Med. 1950 Jun;35(6):865–868. [PubMed] [Google Scholar]
  11. SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wolfson W. Q., Levine R., Tinsley M. THE TRANSPORT AND EXCRETION OF URIC ACID IN MAN. I. TRUE URIC ACID IN NORMAL CEREBROSPINAL FLUID, IN PLASMA, AND IN ULTRAFILTRATES OF PLASMA. J Clin Invest. 1947 Sep;26(5):991–994. doi: 10.1172/JCI101894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. YU T. F., BERGER L., STONE D. J., WOLF J., GUTMAN A. B. Effect of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions. Proc Soc Exp Biol Med. 1957 Oct;96(1):264–267. doi: 10.3181/00379727-96-23450. [DOI] [PubMed] [Google Scholar]
  14. YU T. F., GUTMAN A. B. Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med. 1955 Nov;90(2):542–547. doi: 10.3181/00379727-90-22094. [DOI] [PubMed] [Google Scholar]
  15. YU T. F., GUTMAN A. B. Ultrafiltrability of plasma urate in man. Proc Soc Exp Biol Med. 1953 Oct;84(1):21–24. doi: 10.3181/00379727-84-20528. [DOI] [PubMed] [Google Scholar]
  16. YU T. F., PATON B. C., CHENKIN T., BURNS J. J., BRODIE B. B., GUTMAN A. B. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent. J Clin Invest. 1956 Apr;35(4):374–385. doi: 10.1172/JCI103288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. YU T. F., SIROTA J. H., BERGER L., HALPERN M., GUTMAN A. B. Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med. 1957 Dec;96(3):809–813. doi: 10.3181/00379727-96-23616. [DOI] [PubMed] [Google Scholar]
  18. YU T. F., SIROTA J. H., GUTMAN A. B. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest. 1953 Nov;32(11):1121–1132. doi: 10.1172/JCI102836. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES